In this talk, Dr. Nick Gregg presents cutting‑edge work on mapping thalamic networks to develop personalized neuromodulation therapies for drug‑resistant epilepsy. He begins with the case of a patient who continued to suffer daily seizures despite a frontal lobectomy and anterior thalamic DBS—highlighting the limitations of current one‑target‑fits‑all approaches. Dr. Gregg explains that unlike movement disorders with predictable circuits, each person’s seizure network is unique, and seizures